
Opinion|Videos|May 15, 2024
Overview of Efficacy and Safety Data for Current CLL Treatment Options
A general overview of efficacy and safety data for current treatment options for patients with chronic lymphocytic leukemia.
Advertisement
Episodes in this series

Advertisement
Related to this article

Dr. Elham Vosoughi, a breast medical oncologist at UCSF, discusses new breast cancer treatments, clinical trials and why genetic testing matters for families.

Through years of reflection, relationships and lessons from the ocean, I learned that accepting my scars was a gradual process.

Chemotherapy-free regimens for lymphoma and new drug combinations for myeloma are among the ASH 2026 studies patients should watch.

Births to cancer survivors in U.S. hospitals rose from 2016 to 2023, and most went to full term, but survivors had more serious delivery complications than people who never had cancer, a large study found.

Jessica Tovar, owner of Ink Esthetics, explained how paramedical tattooing can help restore the appearance of the areola and support patients after breast cancer surgery.

A registered nurse and breast cancer survivor, JoAnne Page became her husband Ray's care partner when his cancer stopped responding to treatment.

Told her metastatic breast cancer was terminal, a woman still alive four years later shares life as an In-Betweener and why society still hasn't caught up.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Nelkarmi for Previously Treated ALK+ Lung Cancer
2
The In-Betweeners: Living Longer With Metastatic Breast Cancer
3
FDA Approves Wilserdly Combo for ESR1-Mutated Breast Cancer
4
5 FDA Approvals From This Fall That People With Cancer Should Know
5



